undamentalytics Newsletter
Sign in

Sarepta Therapeutics, Inc. trades by members of Congress

Purchases and sales of Sarepta Therapeutics, Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 0 trades None disclosed
Sales, last 12 months 0 trades None disclosed
Members trading, last 12 months 0 17 purchases and sales since January 3, 2015
Report
Gilbert Ray Cisneros, Jr. House · D-CA 31 Sale (full)$1,001 - $15,000 May 6, 2025 Apr 14, 2025 Filing
Josh Gottheimer House · D-NJ 5 Purchase$1,001 - $15,000 · Joint Aug 21, 2023 Jul 14, 2023 Filing
Josh Gottheimer House · D-NJ 5 Sale (full)$1,001 - $15,000 · Joint Jul 11, 2023 Jun 13, 2023 Filing
Daniel S. Goldman House · D-NY 10 Sale (full)$15,001 - $50,000 May 19, 2023 Apr 10, 2023 Filing
Josh Gottheimer House · D-NJ 5 Purchase$1,001 - $15,000 · Joint Apr 20, 2023 Mar 6, 2023 Filing
Daniel S. Goldman House · D-NY 10 Purchase$15,001 - $50,000 Apr 17, 2023 Mar 6, 2023 Filing
Daniel S. Goldman House · D-NY 10 Sale (full)$1,001 - $15,000 Feb 24, 2023 Jan 31, 2023 Filing
Josh Gottheimer House · D-NJ 5 Sale (full)$1,001 - $15,000 · Joint Dec 9, 2020 Nov 6, 2020 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Purchase$1,001 - $15,000 Oct 14, 2020 Sep 14, 2020 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Sale (partial)$1,001 - $15,000 Jul 17, 2020 Jun 10, 2020 Filing
Josh Gottheimer House · D-NJ 5 Purchase$1,001 - $15,000 · Joint Jan 6, 2020 Dec 13, 2019 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Purchase$1,001 - $15,000 Nov 15, 2019 Oct 11, 2019 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Purchase$1,001 - $15,000 Nov 15, 2019 Oct 10, 2019 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Purchase$1,001 - $15,000 May 14, 2019 Apr 9, 2019 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Purchase$1,001 - $15,000 Apr 16, 2019 Mar 11, 2019 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Purchase$1,001 - $15,000 Mar 8, 2019 Feb 27, 2019 Filing
Gilbert Ray Cisneros, Jr. House · D-CA 39 Purchase$1,001 - $15,000 Mar 8, 2019 Feb 26, 2019 Filing

When several House members traded Sarepta Therapeutics, Inc.

Months when 2 or more House members became net buyers, or 3 or more net sellers, of Sarepta Therapeutics, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. Only House members' electronic trade reports are included; Senate reports and reports filed on paper are not. After the 2 buying crowds with six months of prices, it averaged +8.8% against the index. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
April 28, 20232 buying−22.2%−12.4%−19.3%
January 31, 20202 buying+9.3%+29.9%−41.5%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Sarepta Therapeutics, Inc. · Insider trading · Funds · All trades by members of Congress